Global Intravascular Temperature Management Market

1 INTRODUCTION OF GLOBAL INTRAVASCULAR TEMPERATURE MANAGEMENT MARKET
1.1 Overview of the Market
1.2 Scope of Report
1.3 Assumptions

2 EXECUTIVE SUMMARY

3 RESEARCH METHODOLOGY OF VERIFIED MARKET INTELLIGENCE
3.1 Data Mining
3.2 Validation
3.3 Primary Interviews
3.4 List of Data Sources

4 GLOBAL INTRAVASCULAR TEMPERATURE MANAGEMENT MARKET OUTLOOK
4.1 Overview
4.2 Market Dynamics
4.2.1 Drivers
4.2.2 Restraints
4.2.3 Opportunities
4.3 Porters Five Force Model
4.4 Value Chain Analysis
4.5 Regulatory Framework

5 GLOBAL INTRAVASCULAR TEMPERATURE MANAGEMENT MARKET, BY MEDICAL CONDITION
5.1 Overview
5.2 Cardiac Arrest
5.3 Traumatic Brain Injury (TBI)
5.4 Stroke (Bleeding & Thrombosis)
5.5 Myocardial Infarction
5.6 Other Medical Conditions

6 GLOBAL INTRAVASCULAR TEMPERATURE MANAGEMENT MARKET, BY APPLICATION
6.1 Overview
6.2 Perioperative Care
6.3 Acute/Critical Care
6.4 Intensive Care Units
6.5 Coronary Care Units
6.6 Neurological Care Units
6.7 Catheterization Laboratories

7 GLOBAL INTRAVASCULAR TEMPERATURE MANAGEMENT MARKET, BY OPERATIVE CARE
7.1 Overview
7.2 Preoperative Care
7.3 Operative Care
7.4 Post-Operative Care

8 GLOBAL INTRAVASCULAR TEMPERATURE MANAGEMENT MARKET, BY TYPE
8.1 Overview
8.2 Intravascular Cooling
8.3 Intravascular Warming

9 GLOBAL INTRAVASCULAR TEMPERATURE MANAGEMENT MARKET, BY GEOGRAPHY
9.1 Overview
9.2 North America Regional Market Estimates and Forecasts, 2012 - 2025
9.2.1 U.S.
9.2.2 Canada
9.2.3 Mexico
9.3 Europe Regional Market Estimates and Forecasts, 2012 - 2025
9.3.1 Germany
9.3.2 U.K.
9.3.3 France
9.3.4 Rest of Europe
9.4 Asia Pacific Regional Market Estimates and Forecasts, 2012 - 2025
9.4.1 China
9.4.2 Japan
9.4.3 India
9.4.4 Rest of Asia Pacific
9.5 Latin America Regional Market Estimates and Forecasts, 2012 - 2025
9.5.1 Brazil
9.5.2 Argentina
9.6 Rest of the World Regional Market Estimates and Forecasts, 2012 â€" 2025

10 GLOBAL INTRAVASCULAR TEMPERATURE MANAGEMENT MARKETCOMPETITIVE LANDSCAPE
10.1 Overview
10.2 Company Market Share
10.3 Vendor Landscape
10.4 Key Development Strategies

11 COMPANY PROFILES
11.1 Zoll Medical Corporation
11.1.1 Overview
11.1.2 Financial Performance
11.1.3 Product Outlook
11.1.4 Key Developments

11.2 Stryker Corporation
11.2.1 Overview
11.2.2 Financial Performance
11.2.3 Product Outlook
11.2.4 Key Developments

11.3 Medtronic PLC
11.3.1 Overview
11.3.2 Financial Performance
11.3.3 Product Outlook
11.3.4 Key Developments

11.4 Smiths Medical
11.4.1 Overview
11.4.2 Financial Performance
11.4.3 Product Outlook
11.4.4 Key Developments

11.5 3M Company
11.5.1 Overview
11.5.2 Financial Performance
11.5.3 Product Outlook
11.5.4 Key Developments

11.6 Becton, Dickinson and Company
11.6.1 Overview
11.6.2 Financial Performance
11.6.3 Product Outlook
11.6.4 Key Developments

11.7 Gentherm Corporation
11.7.1 Overview
11.7.2 Financial Performance
11.7.3 Product Outlook
11.7.4 Key Developments

11.8 The Surgical Company Group
11.8.1 Overview
11.8.2 Financial Performance
11.8.3 Product Outlook
11.8.4 Key Developments

11.9 Belmont Instrument Corporation
11.9.1 Overview
11.9.2 Financial Performance
11.9.3 Product Outlook
11.9.4 Key Developments

11.10 Biegler GmbH
11.10.1 Overview
11.10.2 Financial Performance
11.10.3 Product Outlook
11.10.4 Key Developments

12 Appendix
12.1 Related Reports